neuroClues® Secures €10 Million in Series A Fundraising for AI-Powered Neurological Biomarkers Expansion

Osborne Clarke has advised neuroClues®. neuroClues®, a European MedTech company powered by P3Lab SRL, has completed a €10 million Series A investment round. The funding round…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here